SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-214127
Filing Date
2020-08-10
Accepted
2020-08-10 07:51:38
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d830828d10q.htm   iXBRL 10-Q 980591
2 EX-31.1 d830828dex311.htm EX-31.1 11142
3 EX-31.2 d830828dex312.htm EX-31.2 11136
4 EX-32.1 d830828dex321.htm EX-32.1 4962
5 EX-32.2 d830828dex322.htm EX-32.2 4956
  Complete submission text file 0001193125-20-214127.txt   3795396

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20200630.xsd EX-101.SCH 33286
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20200630_cal.xml EX-101.CAL 18773
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20200630_def.xml EX-101.DEF 235322
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20200630_lab.xml EX-101.LAB 280450
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20200630_pre.xml EX-101.PRE 269357
11 EXTRACTED XBRL INSTANCE DOCUMENT d830828d10q_htm.xml XML 382311
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 201087148
SIC: 2834 Pharmaceutical Preparations